Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastric, Gastroesophageal Junction (GEJ), or Esophageal Cancer


( Last Updated : May 12, 2022)
Project Status:
In Progress
In Progress
Therapeutic Area:
Esophageal or Gastroesophageal Junction Cancer
Project Line:
Reimbursement Review
Project Sub Line:
Provisional Funding Algorithm
Project Number:
PH0010-000

Details


Provisional Funding Algorithm

Stakeholder Input Deadline:

April 7, 2022

Draft Report Posted:

May 12, 2022

Stakeholder Feedback Deadline:

May 19, 2022

Final Report Posted (Target):

June 20, 2022